Last edition
News about Drug Discovery & Development
Helsinn Signs License Deal with Angelini Pharma to Commercialize AULIN and MESULID
Helsinn Group has signed Distribution and Licence Agreement renewal with Angelini Pharma in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic for AULIN and MESULID (Nimesulide) for the treatment of acute (short-term) pain.
Drug Discovery & Development | 29/05/2024 | By Aishwarya | 710
Nona Biosciences Signs License Deal with AstraZeneca for Monoclonal Antibody Development
Nona Biosciences has signed a license deal with AstraZeneca for preclinical monoclonal antibodies that will be used to create targeted therapies in oncology.
Drug Discovery & Development | 27/05/2024 | By Aishwarya | 399
DelSiTech Enters into Licensing Deal with Global Pharma Firm for Drug Delivery
DelSiTech Ltd. has entered into a Licensing Agreement with an undisclosed global pharmaceutical company.
Drug Discovery & Development | 23/05/2024 | By Aishwarya | 694
Cipla Gets Final FDA Approval for Lanreotide Injection
Cipla Ltd. has received the final approval for its Abbreviated New Drug Application (ANDA) for Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL from the United States Food and Drug Administration (US FDA).
Drug Discovery & Development | 23/05/2024 | By Aishwarya | 1409
Galapagos, BCA to Boost Decentralized CAR-T Manufacturing Network in US
Galapagos has inked a strategic partnership with Blood Centers of America (BCA) for the decentralized manufacturing of Galapagos’ CAR-T cell therapies through BCA’s network in the US.
Drug Discovery & Development | 17/05/2024 | By Aishwarya | 298
Venous thromboembolism (VTE) is a significant medical condition characterized by the formation of blood clots within the deep venous system.
Drug Discovery & Development | 16/05/2024 | By Manvi | 501
CASI Pharmaceuticals Advances CID-103 into Clinical Development for Chronic Immune Thrombocytopenia
CASI received a letter from the FDA indicating clearance for the study to proceed, signaling regulatory approval for the advancement of CID-103 into clinical trials.
Drug Discovery & Development | 16/05/2024 | By Abha | 631
Roquette Unveils New LYCAGEL Flex Softgel Capsule Shell System
Roquette has developed its new LYCAGEL Flex hydroxypropyl pea starch premix for nutraceutical and pharmaceutical softgel capsules.
Drug Discovery & Development | 15/05/2024 | By Aishwarya | 397
Sartorius, Sanofi to Develop End-to-End Platform for Downstream Process Intensification
Sartorius has joined hands with Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing.
Drug Discovery & Development | 14/05/2024 | By Aishwarya | 827
Fulcrum Signs License Deal with Sanofi for Development of Losmapimod in FSHD
Fulcrum Therapeutics has entered into a collaboration and license agreement with Sanofi for the development and commercialization of losmapimod.
Drug Discovery & Development | 14/05/2024 | By Aishwarya | 348
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy